Objective Human T-lymphotropic virus type 1 (HTLV-I) causes adult T-cell leukemia/lymphoma (ATLL), and is associated with chronic inflammatory diseases, including inflammatory pulmonary diseases. HTLV-I bZIP factor (HBZ), which is expressed in all adult T-cell leukemia cells, plays a critical role in the development of lymphoma and systemic inflammation. HTLV-I is harbored by CD4 + T cells that express forkhead box P3 (Foxp3), and HBZ interacts with Foxp3. This study investigated the chest computed tomography (CT) findings and expression of HBZ and Foxp3 in the bronchoalveolar lavage (BAL) cells from patients with HTLV-I-associated lung disorders. Methods CT scans obtained from 37 patients (10 men and 27 women, aged 37-77 years) with HTLV-Iassociated lung disorders were retrospectively evaluated. The expression levels of HBZ and Foxp3 mRNA in BAL cells and the levels of inflammatory cytokines in the BAL fluid (BALF) from patients were compared with those in control subjects.
. It has been reported that there is an elevation in the levels of soluble interleukin-2 receptors in the bronchoalveolar lavage fluid (BALF) (2), along with increased expression of mRNA transcripts for inflammatory cytokines and chemokines in the bronchoalveolar lavage (BAL) cells of patients with HTLV-I-associated lung disorders (3, 4) . The expression of some cytokines and tax (a factor implicated in HTLV-1 pathogenesis) mRNA expression correlated with the proportion of lymphocytes in the BALF (4). These data suggest that HTLV-I infection induces pulmonary inflammation, at least partially via the local production of inflammatory cytokines. The manifestations of these inflammatory pulmonary involved in HTLV-I-infected patients vary widely, and include bronchiolitis, alveolitis, diffuse panbronchiolitis (DPB) and interstitial pneumonia (5) (6) (7) (8) (9) . We recently reported on four HTLV-I-infected patients with histology corresponding to nonspecific interstitial pneumonia (NSIP) (10) . NSIP is one of the subtypes of idiopathic interstitial pneumonia, which was first described by Katzenstein and Fiorelli (11) , and is a Others: coin lesions (n = 3); localized consolidation (n = 1); organizing pneumonia (n = 1); usual interstitial pneumonia (n = 1); diffuse GGO and centrilobular nodules (n=1); localized GGO (n=1). CD: collagen disease, HAM: HTLV-I-associated myelopathy Table 2 . Chest Radiographic Findings of HTLV-I Carriers histopathological pattern that is often seen in patients with immunodeficiency, following exposure to certain drugs or environments and in those with some connective tissue diseases. Using chest computed tomography (CT), the most common findings of NSIP are lower lobes with peripherally predominant ground-glass opacity and reticular abnormalities, traction bronchiectasis and lower lobe volume loss without honeycomb formation (12, 13) . NSIP has rarely been reported among patients with HTLV-I-associated pulmonary involvement.
The proviral form of HTLV-I contains a unique region known as pX (14, 15) . The pX region is located between the env gene and the 3' long terminal repeat (LTR) that encodes viral accessory genes, including tax and HTLV-1 bZIP factor (HBZ) (16) , which are implicated in viral infectivity and the proliferation of infected cells (17) (18) (19) . It is well known that tax activates transcriptional factors and plays a critical role in HTLV-I pathogenesis. However, tax transcripts are detected in only approximately -40% of adult Tcell leukemia (ATL) cases (15) .
It has been shown that HBZ is constitutively expressed in both HTLV-I-infected cells and ATL cells (17) . The transgenic expression of HBZ results in the development of T-cell lymphomas and systemic inflammatory diseases, including lung lesions in mice (20) . Furthermore, the expression of HBZ correlates with the levels of inflammatory markers and the disease severity in HAM/TSP patients (21, 22) . It has also been reported that ATL cells strongly express Foxp3; a marker specific for CD4 + CD25 + regulatory T-cells (23) (24) (25) . HBZ has been demonstrated to interact with Foxp3, and therefore, tax may be critical for disease initiation, while HBZ may promote disease progression. We have hypothesized that tax and HBZ both play critical roles in the pulmonary involvement of HTLV-I infection.
In this study, we investigated whether the NSIP pattern could be a manifestation of the pulmonary involvement in HTLV-I-infected patients. We evaluated the expression levels of tax and HBZ mRNA transcripts in BAL cells, and the levels of inflammatory cytokines in the BALF.
Materials and Methods

Subjects
Our study was reviewed and approved by the ethics review board of the University of the Ryukyus. The subjects investigated in our study were 37 HTLV-I carriers (10 men and 27 women, aged 37-77 years) who had lung disorders or respiratory symptoms, and visited the pulmonary division of the University of the Ryukyus Hospital from 1993 to 2010. The selection criteria for inclusion in the study were as follows: 1) chest CT scans were obtained, 2) BAL was performed and BALF was obtained and 3) there was no concurrent ATLL or development of ATLL. ATLL cells or other malignant cells were not detected in the BALF cytology or specimens obtained from the transbronchial lung biopsies in any cases in this study. We also excluded the presence of other infections, malignancy or other pulmonary diseases. HTLV-I seropositivity was determined using the particle agglutination method (New Seroclit-anti-HTLV-1; Sanko, Tokyo, Japan). Eight control subjects were also included who were seronegative for HTLV-1 (four men and four women, aged 15-69 years). The CT findings and the results of the BAL analyses are shown in Table 1 .
Case 38 had no symptoms, and bronchoscopy was performed to investigate a linear band in the lower lobe of left lung. It revealed old inflammatory changes. Case 39 had no symptoms, and bronchoscopy was performed to investigate a lung tumor, and revealed round atelectasis. Six of the eight control patients had normal chest radiographic findings. Cases 40-42 had uveitis, and bronchoscopy was performed to exclude sarcoidosis. Bronchoscopy was performed to investigate chronic cough in the remaining three patients. They did not have abnormal findings in the BALF analysis and there were no signs of malignancy or active inflammation. We considered these patients to be control subjects.
Chest CT findings
Chest CT examinations were performed with a GE Light Speed scanner (GE medical systems, WI) or an Aquillion CT scanner (Toshiba Medical Systems, Tochigi, Japan). Patients diagnosed with concurrent infectious diseases by serological tests, and/or based on the clinical and pathological findings were excluded from this study. Three Japanese board-certified pulmonologists retrospectively interpreted the chest CT scans. The chest CT images were assessed with respect to the radiological patterns. NSIP patterns were categorized according to the ground-glass opacity and/or homogeneity of the reticular pattern, with neither consolidation nor honeycombing. DPB-like patterns were defined as small centrilobular nodules with branching linear opacities, with a tree-in-bud appearance. Other abnormalities, including consolidation and honeycombing, were considered to be part of the "other" group.
BAL and cell preparation
BAL was performed as described previously (4) . Under local anesthesia, a fiberscope was inserted into the middle lobe, and 150 mL of sterile saline solution in three 50-mL aliquots, was instilled. The fluid was recovered by gentle aspiration into a sterile syringe, and was passed through two gauze sheets. The BALF was transported to a laboratory at 4 within 30 min. The BAL cells were pelleted by centrifugation (1,400 × g, 10 min, 4 ), and the supernatant was collected and stored at -80 for further experiments. After being washed twice with calcium-and magnesiumfree phosphate-buffered saline (PBS) supplemented with 1% heat-inactivated fetal calf serum (FCS), the total cells were counted using a hemocytometer. An aliquot was adjusted to 1×10 6 cells/mL, and the proportion of CD4 + , CD8 + and CD25 + cells were analyzed by flow cytometry (EPICS XL System II; Beckman Coulter, Fullerton, CA) after staining with a fluorescein isothiocyanate (FITC)-conjugated anti-CD4 or anti-CD8 monoclonal antibody (mAbs) (DAKO, Glostrup, Denmark) or a phycoerythrin (PE)-conjugated anti-CD25 mAb (DAKO). The remaining cells from the BALF were lysed in 1 mL of Isogen (Nippon Gene, Tokyo, Japan) and stored at -80 until required for subsequent analyses.
RNA isolation and quantitative PCR (qPCR) assays
To investigate the association of HTLV-1 infection with pulmonary involvement, we examined the tax, HBZ Table 1 ). Total RNA was extracted from the BAL cells using Isogen (Nippon Gene; Tokyo, Japan), and reverse transcription was conducted using 1 μg of sample RNA with a high capacity reverse transcription kit (Applied Biosystems, CA, USA), following the manufacturer's instructions. All qPCR assays were performed using the ABI Prism 7000 sequence detection system. The primer sequences for tax mRNA transcript detection were 5'-ATC CCG TGG AGA CTC CTC AA-3' and 5'-CCA AAC ACG TAG ACT GGG TAT CC-3, along with a specific probe (5'-TCC AAC ACC ATG GCC CAC TTC CC-3') (26) . The sequences of the primers used for spliced HBZ mRNA transcript detection were 5'-AGA ACG CGA CTC AAC CGG-3' and 5'-TGA CAC AGG CAA GCA TCG A-3'; and the probe sequence was 5'-TGG ATG GCG GCC TCA GGG CT-3' (21). For the detection of Foxp3 mRNA transcripts, an established Taqman assay was used (Catalog number 4331182; Applied Biosystems, CA). For internal calibration of the qPCR assays, we used primers and probes specific for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Applied Biosystems, CA).
Determination of the cytokine levels in the BALF
To explore the possible mechanisms underlying the lung involvement of HTLV-1 infection, we examined the cytokine levels in the BALF from 27 HTLV-1 carriers (cases 1-5, 9, 11-14, 15-23, 25-28, 30 and 34-36, Table 1 ) and five control subjects (cases 38 and 40-43, Table 1 ). The BALF supernatant was concentrated using Centricon-Plus centrifugal filters (Centricon-Plus, Millipore, MA). We measured the cytokine levels in the BALF samples using the human cytokine group I multiplex cytokine assay (17-Plex; Bio-Plex, BioRad, Hercules, CA) and normalized the levels to those of albumin in the BALF. The normalized values were reported as the ratios of the cytokine concentrations in concentrated supernatants of the BALF samples to the albumin concentration in the concentrated BALF supernatants.
Statistical analysis
The data are expressed as the means ± standard deviation. Statistical comparisons were conducted using Student's t-test for the BAL analyses, and the Mann-Whitney U-test for the qPCR results. Pearson's correlation coefficient was used to evaluate the level of correlation. A p-value <0.05 was considered to be significant.
Results
Radiographic findings in patients with HTLV-1-associated lung disorders
Of the 645 patients who underwent BAL, 14.4% (93/645) were HTLV-I-positive. Based on the chest CT findings, bronchiectasis (n=19, 51.3%) was the most frequently observed abnormality. Centrilobular nodules (n=17, 45.9%), ground-glass opacities (n=16, 43.2%), thickening of the bronchovascular bundles (n=13, 35.1%) and reticular shadows (n=9, 24.3%) were also frequently observed. Areas of consolidation were observed in two patients (5.4%) and honeycombing was seen in one patient. The combination of bronchiectasis and centrilobular nodules (n=11, 29.7%), which were frequently observed in the DPB pattern, was the most frequently seen combination, followed by ground-glass opacities and reticular shadows (n=8, 21%). A typical image of a DPB-like pattern is shown in Fig. 1A (case 31, Ta- A B Values are presented as medians (range).
ble 1), and a typical image of the NSIP pattern is shown in Fig. 1B (case 17, Table 1 ). Of the HTLV-I carriers, a DPBlike pattern was observed in 45.9% (17/37) of the patients, and a NSIP pattern was seen in 29.7% of the patients (11/ 37). One patient (case 37, Table 1 ) had normal CT findings. Coin lesions, consolidations, diffuse ground glass opacity and centrilobular nodules and usual interstitial pneumonia were observed in the remaining patients (Table 2) .
BAL analysis
The anti-HTLV-I antibody titers were consistently high in the HTLV-1 carriers (Table 1) . A summary of the results of the BAL analyses for the 37 HTLV-I carriers is presented in Table 3 . The total cell numbers and the percentages of lymphocytes in the BALF samples were significantly increased in HTLV-I carriers compared with the control subjects (3.56×10 5 /mL and 0.78×10 5 /mL, 19% and 9.05%, respectively, p<0.01). The percentages of neutrophils in the BALF samples were also significantly increased in patients with a DPB-like pattern compared with patients exhibiting NSIP and control subjects (30%, 2.1% and 0.9%, respectively, p< 0.01). There were no significant differences in the percentages of T lymphocyte subsets or in the CD4/8 ratios in the BALF samples from HTLV-1 carriers compared to control subjects.
HBZ and tax mRNA expression in BAL cells
To study the association between the tax and HBZ mRNA transcripts in HTLV-1 patients with pulmonary involvement, we performed qPCR assays. We examined 14 patients, seven with a DPB-like pattern and seven with the NSIP pattern in the CT findings. HBZ mRNA was detected in the BAL cells from 13 of the 14 patients ( Fig. 2A) , and tax mRNA was detected in 12 of the 14 patients (Fig. 2B) ; whereas there was no mRNA for either molecule detected in the BAL cells from control subjects. There were no significant differences A B of the expression levels of HBZ and tax mRNA in the BAL cells between patients with the DPB-like and NSIP patterns (data not shown). There was no significant correlation between the tax and HBZ mRNA expression levels.
Foxp3 mRNA in the BAL cells and lymphocytes in the BALF
We used qPCR assays to examine the association between the Foxp3 mRNA transcripts and lymphocytes with the pulmonary involvement in HTLV-I-infected patients. We examined seven patients with a DPB-like pattern (cases 23 Table 1 ). The expression of Foxp3 mRNA transcripts in the BAL cells was increased in the patients compared with that in the control subjects, although the difference was not statistically significant (Fig. 3A) . The expression of Foxp3 mRNA transcripts in the BAL cells positively correlated with the proportion of lymphocytes in the BALF, although the correlation was not statistically significant (Fig. 3B) . The expression levels of Foxp3 mRNA seemed to be higher in patients with the NSIP pattern compared with those with the DPB-like pattern (701.84 and 21.90 respectively; p=0.211), although there was no significant difference between the groups.
Cytokine concentrations in the BALF
There were significant increases in the expression levels of T helper cell type 1 (Th1) related cytokines, including interleukin (IL)-2, IL-12 and interferon (IFN)-γ, in the BALF from HTLV-I carriers with pulmonary involvement compared with control subjects (Fig. 4A-C) . Additionally, the IL-10 levels were also increased in the BALF from HTLV-I carriers with pulmonary involvement compared with control subjects (Fig. 4D ).
Discussion
In this study, we demonstrated that there was increased expression of tax and HBZ mRNA in the BAL cells from patients with HTLV-I-associated lung disorders. Additionally, we showed that a pattern of NSIP in chest CT scans could be one manifestation of HTLV-I-associated lung diseases. A positive correlation was observed between the expression of Foxp3 mRNA and the percentages of lymphocytes in the BALF of patients with HTLV-I-associated lung disorders. C A HLTV-I-associated lung disorders were first described in HAM/TSP patients (27) . Their main manifestations in chest CT scans are centrilobular nodules and bronchiectasis, ground-glass opacities and septal thickening (28, 29) . Previous reports have shown that centrilobular nodules and bronchiectasis, which are mostly observed in the DPB pattern, are predominant in the chest CT scans of HTLV-I carriers (28) . It has also been suggested that the DPB is one of the chronic pulmonary manifestations of HTLV-I infection (30) (31) (32) .
However, other recent studies have suggested that interstitial pneumonia, including NSIP, should be considered one of the manifestations of HTLV-I-associated lung disorders (29) . We recently reported four HTLV-I-infected patients with histological signs of NSIP (10) . The characteristic manifestations of NSIP in chest CT scans are ground-glass attenuation and irregular linear or reticular abnormalities. In contrast, the formation of honeycombing and consolidation are infrequently seen (13, 33, 34) .
We included one HTLV-1 carrier who had normal CT findings in the present study because she had respiratory symptoms and lymphocytosis in the BALF (case 37, Table 1). It has been unclear whether lymphocytosis in the BALF is associated with pulmonary involvement, or if it is a common phenomenon in patients infected with HTLV-1 in this study. However, a previous report showed higher percentages of lymphocytes and higher levels of β chemokines in the BALF samples of asymptomatic carriers compared with non-infected control subjects (3). This indicated that T lymphocytic alveolitis had developed in the patient, and suggests that some HTLV-1 carriers have similar pulmonary involvement in spite of normal chest CT findings.
Among the 37 patients in the present study, we observed the NSIP pattern in 11. These results indicate that not only the DPB-like pattern, but also the NSIP pattern, in chest CT scans is suggestive of lung involvement in HTLV-I-infected patients. The percentages of lymphocytes in the BALF were not significantly different between patients with the NSIP pattern and patients with the DPB-like pattern, whereas the percentages of neutrophils in the BALF were increased in patients with the DPB-like pattern (Table 3) . We could not rule out the possibility that the inflammatory changes associated with the NSIP and DPB patterns are the cause of the differences in the BALF analysis. It would be necessary to compare the results of a BALF analysis of HTLV-1 carriers and non-HTLV-1 carriers with the same radiographic pattern in order to precisely evaluate the influence of HTLV-1 infection. It is well known that the HTLV-1 provirus is predominantly detected in CD4+ T lymphocytes (35) , and that ATL is characterized by malignant CD4+ T cell proliferation (36) . It is notable that the BALF of three patients with the NSIP pattern was found to have more than 60% CD4+ cells (cases 11, 16 and 17, Table 1 ). However, we followed these three patients (case 11, 16 and 17, Table 1 ) for up to nine years, and none of them developed ATLL. The other patients with the NSIP also did not develop ATLL while we followed them.
It has been reported that there is an increase in lymphocytes, with a similar or decreased CD4/8 ratio in the BALF from NSIP patients (37) (38) (39) . Our present results showed that the HTLV-1 carriers with the NSIP pattern tended to have high percentages of CD4+ cells and a high CD4/8 ratio (1.8±2.8) in the BALF cells. This may suggest that infected CD4+ T cells are involved in the development of the NSIP pattern in HTLV-1-associated pulmonary disorders. Further studies of the mechanisms involved, and a better understanding of the etiology of these pulmonary manifestations are required.
HTLV-I encodes several regulatory and accessory genes in the pX region located between env and the 3' LTR. The pX region encodes tax, rex, p30, p12, p13 and HBZ. Among these genes, tax is thought to play a central role in proliferation and inflammation. It is well known that tax activates several transcriptional pathways, including the nuclear factor κB (NF-κB) and Akt pathways (15) , to promote cell survival and proliferation. In addition, tax can inhibit apoptosis by inactivating p53 (40) . However, despite its role in the proliferation of infected cells, tax transcripts are detected in only -40% of all ATL cells (15) . Because tax is the major target of cytotoxic T lymphocytes in vivo, the loss of tax expression likely enables ATL cells to escape the host immune system.
In contrast, HBZ is a viral transcript encoded by the minus strand of the HTLV-I provirus. It is consistently expressed in all ATL cells. The HBZ gene also promotes the proliferation of ATL cells (17) . A recent study showed that HBZ-Tg mice developed inflammation of the skin, and of the alveolar septa in the lungs. The incidence of these inflammatory changes correlated with the HBZ expression levels (20) . Furthermore, it has been reported that there is a correlation between the HBZ expression levels and the severity of HAM/TSP (21, 22) . These findings suggest that HBZ might contribute to the development of HTLV-Iassociated chronic inflammatory diseases, including lung disorders. In this study, we observed high expression levels of tax and HBZ mRNA in the BAL cells from patients with HTLV-I-associated lung disorders. The expression levels of tax mRNA seemed to be higher in patients with the DPBlike pattern compared with those who had the NSIP pattern, and the expression levels of HBZ mRNA seemed to be higher in those with the NSIP pattern compared with those who had the DPB-like pattern, although there was no significant differences between the groups. However, the expression levels of tax mRNA and HBZ mRNA varied widely, which likely contributed to the lack of statistically significant differences between the groups.
To the best of our knowledge, this is the first time that the expression of HBZ mRNA in the BAL cells of patients with HTLV-I-associated lung disorders has been reported. However, in this study, there were no significant correlations between the HBZ mRNA expression levels and other inflammatory cytokines or lymphocytosis in the BALF samples. A possible explanation for this could be the limited numbers of subjects that we investigated. In addition, we were unable to determine the proviral load at the time points examined because of a lack of peripheral blood mononuclear cells (PBMCs).
In HAM/TSP, which is similar to the chronic inflammatory diseases associated with HTLV-I, the infected T-cells trigger a strong virus-specific immune response. This leads to increased production of pro-inflammatory cytokines and chemokines, thus resulting in chronic lymphocytic inflammation of the nervous system. The expression of HBZ mRNA transcripts, normalized to the HTLV-I proviral load, correlates with the severity of HAM/TSP (22) . Further studies are needed to clarify whether high expression levels of HBZ mRNA in the lung are associated with lung involvement in HTLV-I-infected patients.
Foxp3, a transcription factor of the forkhead/winged-helix family, is specifically expressed in CD4 + CD25 + regulatory T cells (41, 42) . Regulatory T cells are known as negative regulators of the host immune response. Several studies have shown the dysregulation of Foxp3 expression in human inflammatory diseases. In the case of HTLV-I infection, it has been reported that a proportion of the HTLV-I-infected CD4 + T cells express Foxp3, and that HTLV-I infection induces an abnormal frequency and phenotype of Foxp3 + CD4 + T cells in HAM/TSP patients (43) . In this study, we found that the high expression levels of Foxp3 mRNAs in the BAL cells tended to positively correlate with the proportion of lymphocytes in the BALF from patients with HTLV-I-associated lung disorders. These findings indicate that there are an increased number of Foxp3 + T cells, which are potential regulatory T cells, in the lungs of patients with HTLV-Iassociated lung disorders. A recent report showed that HBZ expression increases the number of regulatory T cells by inducing the transcription of Foxp3 in transgenic mice which express HBZ in CD4 + T cells (20) . These transgenic mice developed inflammation in the lungs (20) . Therefore, HBZ appears to play a critical role in the pathogenesis of HTLV-I infection-induced lung inflammation via Foxp3 expression in the lungs.
Previous studies have shown increased expression of inflammatory cytokines in the BALF samples from patients with HAM/TSP and HTLV-I-associated lung disorder. In the present study, we found increased expression of IL-2, IL-10, IL-12 and IFN-γ in the BALF samples. It is commonly known that tax activates cellular signaling pathways, and transactivates cellular immune responses, including those leading to cytokine production. We previously reported that there were increased mRNA expression levels of Th1 related cytokines and chemokines in the lungs of transgenic mice bearing the pX region (44) , with a significant correlation between the tax mRNA expression levels and pathological inflammatory changes in the lungs of these transgenic mice (45) .
In the present study, we found that there was a significant increase in the IL-10 levels in the BALF samples of patients with HTLV-I-associated lung disorders. IL-10 is an antiinflammatory cytokine with a critical role in preventing inflammatory and autoimmune pathologies (46) . Recent studies have suggested that the production of IL-10 is associated with the tolerance of regulatory T cell responses during chronic inflammation (47) . Carvalho et al. reported that both Th1 and Th2 cytokines are elevated in asymptomatic HTLV-I-infected carriers, and that IL-10 suppresses the IFN-γ production from PBMCs of HTLV-I carriers (48) . It seems likely that the production of IL-10 could be part of a feedback system that regulates the immune response, and its upregulation may indicate an attempt to downregulate T cell activation in patients with HTLV-I infections.
In summary, we herein demonstrated that there are increased expression levels of tax and HBZ mRNA in the BAL cells from patients with HTLV-I-associated lung disorder, and showed that an NSIP pattern in the chest CT findings could be one of the manifestation of HTLV-Iassociated lung diseases. Interestingly, the increased expression of Foxp3 mRNA had a tendency to be correlated with the percentages of lymphocytes in the BALF, suggesting the involvement of regulatory T cells in the pathologies of HTLV-I-associated lung disorders. Because the lungs are continuously exposed to a variety of stimuli, and because of the high risk of pneumonia due to HTLV-I-induced immunodeficiency in hosts (49), HTLV-I-associated lung disorders are varied and difficult to accurately diagnose. Direct evidence of HTLV-I infection and lung involvement has not been clearly obtained, and the mechanism(s) of pathogenesis remain to be elucidated. Further studies are required to determine the pathology of this disease and to better clarify its clinical features.
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